Executive Committee

Expert Meetings

The Executive Committee (EC) is responsible for making decisions about the overall direction and strategy for CTTI. The EC includes distinguished U.S. and international thought leaders in government, academia, industry, and patient advocacy who are experienced at envisioning and facilitating improvements in health care and medical research systems. This group ensures that CTTI informs and facilitates meaningful improvements to the design and conduct of clinical trials. Below is a list of our EC members:

Leadership

Mark B McClellan, MD, PhD
Chair

Robert J. Margolis Professor of Business, Medicine, and Policy
Director, Duke-Margolis Center for Health Policy, Duke University

John Alexander, MD, MHS, FACC
Co-Chair

Cardiologist and Professor of Medicine, Department of Medicine
Director of Cardiovascular Research, Duke Clinical Research Institute, Duke University

M. Khair Elzarrad, PHD, MPH
Co-Chair

Deputy Director of the Office of Medical Policy (OMP) at FDA’s Center for Drug Evaluation and Research (CDER)
U.S. Food and Drug Administration

Barbara E. Bierer, MD

Professor of Medicine
Harvard Medical School

Dan M. Cooper, MD

Interim Executive Director of the Institute for Precision Health
University of California-Irvine

Donna R. Cryer, JD

President and Chief Executive Officer
Global Liver Institute

Michael S. Cuffe, MD, MBA

Executive Vice President and Chief Clinical Officer
HCA Healthcare

Rachael L. Fleurence, PhD, MSc

Senior Advisor, National Institutes of Health

Pat Furlong

Founding President and Chief Executive Officer Parent Project Muscular Dystrophy (PPMD)

Steven K. Galson, MD, MPH

Senior Advisor
Boston Consulting Group

Patricia Hurley

Director of Strategic Research Initiatives
American Society of Clinical Oncology (ASCO) Center for Research and Analytics

CTTI Steering Committee Liaison

Esther Krofah

Executive Director
FasterCures

Theodore Lystig, PhD, MS

SVP, Chief Analytics Officer
BridgeBio

Virginia Nido

Global Head of Industry Collaborations
Genentech - a Member of the Roche Group

Robert Temple, MD

Deputy Center Director for Clinical Science, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration

Spiros Vamvakas

Scientific Lead/Scientific Adviser on Human Medicines, European Medicines Agency

Bram Zuckerman, MD

Director, Division of Cardiovascular Devices U.S. Food and Drug Administration

Emeritus Members

Susan Alpert, PhD, MD
Jodi Black, PhD
Robert Califf, MD
David DeMets, PhD
Hans-Georg Eichler, MD, MSc
Kenneth Getz, MBA
Dalvir Gill, PhD
Glenn Gormley, MD, PhD
Alberto Grignolo, PhD
John Hubbard, PhD, FCP
Kathy Hudson, PhD

Louis Jacques, MD
Michael Kolodziej, MD
Richard Kuntz, MD, MSc
Michael Lauer, MD
Freda Lewis-Hall, MD
Rod MacKenzie, PhD
Deven McGraw, JD, MPH, LLM
Pierre Meulien, PhD
Briggs Morrison, MD
Garry Neil, MD
Amy Patterson, MD

Richard Platt, MD, MS
Nancy Roach
CDR Melissa Robb
Jean Lucien Rouleau, MD
Joe Selby, MD, MPH
Rachel Sherman, MD, MPH, FACP
Jay Siegel, MD
Veronica Todaro, MPH
Tom Walley, CBE